Skip to content

Author

J. Taupin

We have 1 of 43 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Case report Nov 2026

Innovative Management of Non-HLA Antibody and NK Cell-Mediated Rejection After Kidney Transplantation With Imlifidase: A Case Report.

Integrating dd-cfDNA, transcriptomic biopsy analysis, and non-HLA antibody assessment may optimize the management of highly sensitized KT recipients following imlifidase induction, however, long-term efficacy remains to be confirmed.

F. von Tokarski, Marion Rabant, V. Goutaudier et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.